JNJ
Johnson & Johnson · NYSE
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website jnj.com
- Employees(FY) 152700
- ISIN US4781601046
Performance
+0.31%
1W
-7.27%
1M
-3.35%
3M
+0.58%
6M
-0.01%
YTD
+4.54%
1Y
Profile
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Technical Analysis of JNJ 2024-11-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-20 14:52
- 2024-11-20 14:00
- 2024-11-20 09:47
- 2024-11-19 20:02
- 2024-11-19 17:24
J&J pill clears skin in two late-stage psoriasis studies(Yahoo Finance)
- 2024-11-19 09:02
- 2024-11-19 09:00
- 2024-11-19 05:22
Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis(Clinical Trials Arena)
- 2024-11-19 03:30
- 2024-11-18 16:30
- 2024-11-18 16:28
- 2024-11-18 13:27
- 2024-11-18 11:20
- 2024-11-18 07:42
- 2024-11-17 23:43
Analyst Report: Johnson & Johnson(Yahoo Finance)
- 2024-11-15 20:02
- 2024-11-15 09:02
- 2024-11-15 07:23
Johnson & Johnson MedTech announces partnership for soft tissue solutions(Medical Device Network)
- 2024-11-15 06:51
J&J’s nipocalimab shows promise in Phase II Sjögren’s disease trial(Clinical Trials Arena)
- 2024-11-15 06:10
- 2024-11-14 21:00
- 2024-11-14 11:30
- 2024-11-14 10:00
- 2024-11-13 15:49
Sector Update: Health Care Stocks Softer Late Afternoon(MT Newswires)
- 2024-11-13 13:53
- 2024-11-13 13:32
Sector Update: Health Care(MT Newswires)
- 2024-11-13 12:00
- 2024-11-13 11:58
J&J MedTech wins IDE for Ottava to greenlight trials for surgical robot(Clinical Trials Arena)
- 2024-11-13 11:58
J&J MedTech wins IDE for Ottava to greenlight trials for surgical robot(Medical Device Network)
- 2024-11-13 11:44
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.